Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Designated Drug Use Investigation (Long-Term Administration) of Zetia 10-mg Tablets - A 52-Week Long-Term Designated Drug Use Investigation of Zetia Monotherapy and Combination Therapy

NCT00705211 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00705211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00705211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Designated Drug Use Investigation (Long-Term Administration) of Zetia 10-mg Tablets - A 52-Week Long-Term Designated Drug Use Investigation of Zetia Monotherapy and Combination Therapy
Lead sponsor
Organon and Co
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
December 31, 2009
Enrollment
1,794 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

familial hypercholesterolemia, homozygous sitosterolemia, hypercholesterolemia